Omeros Stock

Omeros Current Liabilities

The Current Liabilities of Omeros (OMER) as of Aug 13, 2026 is 75.59 M USD. In the previous year, Current Liabilities was 153.15 M USD — a change of -50.64% (lower).

Current Liabilities

75.59 MUSD

YoY

-50.64%

Last updated:

Current Liabilities of Omeros is 2026 75.59 M USD. Current Liabilities of Omeros was 2025 153.15 M USD. It decreases by -50.64% lower compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Current Liabilities of Omeros is 75.59 M USD in 2026.

Current Liabilities of Omeros changed from 153.15 M USD to 75.59 M USD, representing a -50.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Omeros since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Omeros historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Omeros

All Key Metrics — Omeros